Shares of Synopsys, Inc. (NASDAQ:SNPS – Get Free Report) have earned a consensus rating of “Hold” from the seventeen brokerages that are presently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and nine have given a buy rating to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $563.8125.
SNPS has been the subject of several analyst reports. Berenberg Bank set a $633.00 price target on shares of Synopsys in a report on Wednesday, May 27th. Needham & Company LLC reissued a “buy” rating and set a $580.00 price target on shares of Synopsys in a report on Thursday, May 28th. Stifel Nicolaus boosted their price target on shares of Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, May 28th. KeyCorp reissued an “overweight” rating on shares of Synopsys in a report on Thursday, May 28th. Finally, Robert W. Baird set a $558.00 price target on shares of Synopsys in a report on Thursday, May 28th.
Check Out Our Latest Research Report on SNPS
Insider Transactions at Synopsys
Institutional Investors Weigh In On Synopsys
Hedge funds and other institutional investors have recently modified their holdings of the stock. Sankala Group LLC bought a new stake in shares of Synopsys during the fourth quarter valued at about $25,000. Thurston Springer Miller Herd & Titak Inc. bought a new stake in shares of Synopsys during the fourth quarter valued at about $28,000. Caitong International Asset Management Co. Ltd bought a new stake in shares of Synopsys during the fourth quarter valued at about $28,000. Atlas Capital Advisors Inc. bought a new stake in shares of Synopsys during the fourth quarter valued at about $32,000. Finally, Phillip James Consulting Co. bought a new stake in shares of Synopsys during the fourth quarter valued at about $36,000. 85.47% of the stock is currently owned by institutional investors.
Synopsys Stock Performance
Shares of SNPS opened at $455.51 on Wednesday. Synopsys has a 1 year low of $376.18 and a 1 year high of $651.73. The company has a market cap of $87.22 billion, a price-to-earnings ratio of 105.44, a price-to-earnings-growth ratio of 2.68 and a beta of 1.22. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. The firm has a fifty day moving average of $479.14 and a 200-day moving average of $462.21.
Synopsys (NASDAQ:SNPS – Get Free Report) last announced its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The company had revenue of $2.28 billion during the quarter, compared to the consensus estimate of $2.25 billion. During the same quarter in the previous year, the company posted $3.67 earnings per share. The company’s revenue for the quarter was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, equities analysts anticipate that Synopsys will post 10.65 earnings per share for the current year.
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Further Reading
- Five stocks we like better than Synopsys
- 3 Inflation-Fighting Stocks Built for Higher Oil Prices
- 3 Biotech Firms With Major Potential Catalysts in the Coming Months
- Applied Materials Stock Looks Pricey—Can AI Demand Justify the Rally?
- 3 Small-Cap Stocks Getting a Russell 2000 Rebalance Boost
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
